CDK-INHIBITOREN
European patent · EP4146647 · In force
Register entry
- Publication number
- EP4146647
- Application number
- EP21727336
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 4, 2021
- Published
- Mar 15, 2023
- Granted
- Apr 15, 2026
- Protection ends at the latest
- May 3, 2041
- Next annual fee due
- May 31, 2027
- IPC classes
- C07D 471/04 (2006.01)A61P 35/00 (2006.01)
- Priority
- WO PCT/CN2020/088585 05.05.2020
- PCT application
- PCT/US2021/030728 04.05.2021
- PCT publication
- WO2021/226140 11.11.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Apr 16, 2026
Agent entered
- Representative
- VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 16.04.2026
- Apr 15, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 15.04.2026
Parties
Inventor
HU, Zhilong
Shanghai, 201314, CN
HE, Hu
Shanghai, 201100, CN
ZHANG, Fei
Shanghai, 201210, CN
ZHONG, Wenge
Thousand Oaks, CA 91362, US
ZHU, Xiaotian
Newton, MA 02465, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.